This study evaluated the clinical activity of RGN-259 (thymosin β4) in comparison with cyclosporine A (CsA), diquafosol (DQS), and lifitegrast (LFA) in a murine model of dry eye. The model was NOD.B10 ...
Find the latest Region Group (RGN.XA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Region Group Annual stock financials by MarketWatch. View the latest RGN financial statements, income statements and financial ratios.
ROCKVILLE, Md., April 13, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx" or "Company"), a clinical-stage drug development company focused on tissue protection, repair ...
At close: 1 May at 4:10:10 pm GMT+10 ...
Regucalcin (RGN) is a potent inhibitory protein of calcium signaling and expresses in various tissues. However, the role of RGN in the tumor immunological microenvironment in lung squamous cell ...
Find the latest Region Group (RGN.AX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results